PharVision Advisers »

Gladstone Commercial Corporation shares owned by PharVision Advisers

Quarter-by-quarter ownership of Gladstone Commercial Corporation (GOOD) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Gladstone Commercial Corporation

Tip: Access up to 7 years of quarterly data

All positions including Gladstone Commercial Corporation held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gladstone Commercial Corporation by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $318k 26k 12.32
2025-06-30 $451k 32k 14.33
2025-03-31 $279k 19k 14.98
2024-12-31 $205k 13k 16.24

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Gladstone Commercial Corporation

Vanguard Group
BlackRock
Renaissance Technologies
State Street Corporation
Geode Capital Management
Invesco
Qube Research & Technologies
Charles Schwab Investment Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
Northern Trust
XML Financial
Jpmorgan Chase & Co
LSV Asset Management
Citadel Advisors

View all funds holding Gladstone Commercial Corporation